For more details on the courses, please refer to the Course Catalog
| Code | Course Title | Credit | Learning Time | Division | Degree | Grade | Note | Language | Availability |
|---|---|---|---|---|---|---|---|---|---|
| BTH5095 | Advanced Chemical Biology 1 | 3 | 6 | Major | Master/Doctor | 1-8 | - | No | |
| Advanced Chemical Biology 1 focuses on small molecules, peptides, nucleic acids which identify and regulate the molecular mechanism of life, and introduces a trend in their technology development and application examples to offer basic concept of drug discovery. Representative technologies in this field include 1. DNA-encoded library; 2. Peptide library; 3. Nucleic acids; 4. Protein degraders etc. The lecture consists of introduction of each technology and the corresponding application for drug discovery and biological phenomena. | |||||||||
| BTH5096 | Advanced Chemical Biology 2 | 3 | 6 | Major | Master/Doctor | 1-8 | - | No | |
| Advanced Chemical Bology 2 focuses on biomacromolecules (or biologics) such as 1. Monoclonal antibody; 2. Bispecific antibody; 3. Nanobody; 4. Affibody. The lecture includes how to develop the corresponding biologics and how to apply them for drug discovery and disease diagnosis. Representative technologies to develop biologics include phage display and molecular evolutions. The students will learn the technology for biotherapeutics developments. | |||||||||
| BTH5097 | Tissue Engineering for Drug Discovery | 3 | 6 | Major | Master/Doctor | English | Yes | ||
| Tissue Engineering is a next-generation biotechnology to create human tissue surrogates in vitro by applying the development and regeneration process of the human body. Tissue Engineering is a promising platform for developing new drugs and it holds a great potential to serve as next-generation biopharmaceuticals for regenerative medicines. In this course, basic concepts/principles of tissue engineering and state-of-the-art tissue engineering strategies such as organoid/3D bioprinting will be covered. In addition, through case studies, tissue engineering techniques currently applied to the pharmaceutical industry will be covered. The goals of this course are as follows: 1) Understanding of tissue engineering principles and state-of-the-art tissue engineering technology, 2) Improving reading comprehension skills of original research articles, and 3) Setting biomedical research problems in real life and proposing problem solving methods using tissue engineering principles. | |||||||||
| COV7001 | Academic Writing and Research Ethics 1 | 1 | 2 | Major | Master/Doctor | SKKU Institute for Convergence | Korean | Yes | |
| 1) Learn the basic structure of academic paper writing, and obtain the ability to compose academic paper writing. 2) Learn the skills to express scientific data in English and to be able to sumit research paper in the international journals. 3) Learn research ethics in conducting science and writing academic papers. | |||||||||
| HST5026 | Gene regulation in eukaryotes | 3 | 6 | Major | Master/Doctor | 1-4 | Health Sciences and Technology | Korean | Yes |
| This is an advanced course emphasizing the mechanism of gene regulation in eukaryotes. Topics will include chromatin structure, histone modification, transcription factors and their coregulators, transcriptional regulation, post-transcriptional regulation, post-translational modification, as well as epigenetics and dysregulation of gene expression in cancers. | |||||||||
| HST5084 | Principle of Bioindustry | 3 | 6 | Major | Master/Doctor | 1-4 | Health Sciences and Technology | Korean | Yes |
| The sciences behind bio-industry are very diverse and complex as a form of convergence of the many fields. This course aim to provide the basic understandings on the nature of Bio-industry by the overview of the major constituting factors to acquire the applicable & professional knowledge. The face to face interaction with the renowned scientists representing the upto-date leaders in diverse bio fields to provide the field experiences. | |||||||||
| HST5097 | Methodologies in Biomedical Sciences | 3 | 6 | Major | Master/Doctor | 1-4 | Health Sciences and Technology | - | No |
| The goal of this course is to provide students with basic principles and advanced methodology in the broad areas of biomedical sciences. The course emphasizes multidisciplinary techniques and recent approaches in protein biochemistry, structural biology, bioimaging, animal biology, and molecular biology. | |||||||||
| IBT4014 | Cancer therapy | 3 | 6 | Major | Bachelor/Master | 1-4 | Integrative Biotechnology | - | No |
| It has been reported that the leading cause of death for Korean in 2019 is cancer related death. So far, many cancer therapy has been developed, however, it can affect the fast-proliferating normal cells, thereby inducing harmful side-effect, or cancer may acquire the resistance for anti-cancer drugs by altering their genetic, transcriptional, epigenetical, metabolic programs as well as via interactions with microenvironment or neighboring cell. Therefore, it is continuously required to develop new anti-cancer therapy. This lecture reviews current cancer therapy, drug-resistance strategies induced by cancer-intrinsic or –extrinsic mechanisms, and introduce and discuss the new developmental strategies for cancer therapy. | |||||||||
| IBT4015 | Cancer Precision Medicine | 3 | 6 | Major | Bachelor/Master | 1-2 | Integrative Biotechnology | - | No |
| The personalized cancer therapy is defined as a therapeutic approach for the cancer patients based on their genetic backgrounds and has provided the patients durable clinical benefit. Thus, this subject will cover the concept of the precision medicine and its clinical application. Additionally, Next Generation Sequencing has been widely used to determine patient’s genetic background, which will be covered in this class as well as covering actual examples | |||||||||
| IBT5009 | Advanced Plant Biochemistry | 3 | 6 | Major | Master/Doctor | 1-8 | Integrative Biotechnology | - | No |
| Introduction to the unique plant metabolisms such as photosynthesis, nitrogen fixation, actions of plant hormones and biosynthesis of secondary metabolites with recently published article. | |||||||||
| IBT5025 | Advanced Topics in Protein Engineering 2 | 3 | 6 | Major | Master/Doctor | 1-8 | Integrative Biotechnology | - | No |
| Structure-function relationship of proteins and application to the industry is lectured in this course. Course is composed of lectures including protein production, purification, characterization, structure, kinetics, regulation, modification of its activity, functional mechanism and analysis. | |||||||||
| IBT5028 | Advanced Genetic Engineering 2 | 3 | 6 | Major | Master/Doctor | 1-8 | Integrative Biotechnology | Korean | Yes |
| In the class of Advanced Genetic Engineering 1, front-edge technologies in the field of genetic engineering are throughly explored to enhance quality of researches. Novel functional biomaterials, investigations on life phenomena, productivity improvement and other subjects are the focus of this study. | |||||||||
| IBT6012 | Special Topics in Genetic Engineering 2 | 3 | 6 | Major | Doctor | 1-4 | Integrative Biotechnology | Korean | Yes |
| Lectures on experimental methods for identification and purification of biopolymers from various organisms, manipulation of biopolymers in vivo and vitro, application of biopolymers to industry. | |||||||||
| IPS5021 | Principles of Pharmacoepidemiology | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| The course will help students acquired a basic understanding of the concepts and practice of pharmacoepidemiology. This course covers inference about the effects of pharmaceuticals from case report, case series, cohort studies, case-constrol studies and odds ratio. relative risk. Then, it is shown how epidemiological techniques are applied to pharmacoepidemiological studies. | |||||||||
| IPS5047 | Regulatory Strategy in Global Market1 | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course has been development to provide a comprehensive understanding of regulatory environment throughout other countries(USA, Europe, Japan etc). Topics include: The structure of other countries regulatory environment, business strategies to maximize the value of product in other countries prior to licensing or understanding the concern/issues of Regulatory Personnel, information required for effective submission. | |||||||||